Bumper Offer - Urjas oil Just @ Rs. 1 X
Tenolol D 50 Mg/1.25 Mg Tablet SR is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Tenolol D 50 Mg/1.25 Mg Tablet SR have also been mentioned below.
The correct dosage of Tenolol D 50 Mg/1.25 Mg Tablet SR depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Tenolol D 50 Mg/1.25 Mg Tablet SR are Blurred vision, Cold hands. Some other side effects of Tenolol D 50 Mg/1.25 Mg Tablet SR have been listed ahead. Such side effects of Tenolol D 50 Mg/1.25 Mg Tablet SR normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Tenolol D 50 Mg/1.25 Mg Tablet SR is Safe for pregnant women and Safe for women who are breastfeeding. Warnings related to Tenolol D 50 Mg/1.25 Mg Tablet SR's effects on the liver, heart and kidney, if any, have been listed below.
Tenolol D 50 Mg/1.25 Mg Tablet SR is contraindicated in people with pre-existing medical conditions like Diabetes, Low Blood Pressure (Hypotension), Asthma as it can result in adverse effects. The section on Tenolol D 50 Mg/1.25 Mg Tablet SR contraindications lists all such conditions.
Drug interactions for Tenolol D 50 Mg/1.25 Mg Tablet SR have been reported in the medical literature. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Tenolol D 50 Mg/1.25 Mg Tablet SR is considered not safe while driving, and is not addictive.
Tenolol D 50 Mg/1.25 Mg Tablet SR is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Tenolol D 50 Mg/1.25 Mg Tablet SR is used -
Moderate
Mild
Common
Is the use of Tenolol D 50 Mg/1.25 Mg Tablet SR safe for pregnant women?
Tenolol D is safe for pregnant women.
Is the use of Tenolol D 50 Mg/1.25 Mg Tablet SR safe during breastfeeding?
Tenolol D is safe for breastfeeding women.
What is the effect of Tenolol D 50 Mg/1.25 Mg Tablet SR on the Kidneys?
There are no side effects of Tenolol D on the kidneys.
What is the effect of Tenolol D 50 Mg/1.25 Mg Tablet SR on the Liver?
Tenolol D has very mild side effects on the liver.
What is the effect of Tenolol D 50 Mg/1.25 Mg Tablet SR on the Heart?
Tenolol D may have mild side effects on the heart. Most people will never see any effect on the heart.
Tenolol D 50 Mg/1.25 Mg Tablet SR should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Tenolol D 50 Mg/1.25 Mg Tablet SR unless your doctor advises you to do so -
Is this Tenolol D 50 Mg/1.25 Mg Tablet SR habit forming or addictive?
No, there is no any evidence that Tenolol D 50 Mg/1.25 Mg Tablet SR is addictive.
Interaction between Food and Tenolol D 50 Mg/1.25 Mg Tablet SR
Some foods when eaten with Tenolol D 50 Mg/1.25 Mg Tablet SR can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Tenolol D 50 Mg/1.25 Mg Tablet SR
Consuming Tenolol D 50 Mg/1.25 Mg Tablet SR with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tenormin® (atenolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 197-198
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lozol® (indapamide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 561